• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthChina

Biotech Giant Thermo Fisher Stops Selling DNA Sequencers in Repressive Chinese Region

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
February 21, 2019, 7:02 AM ET
Video Poster

The Massachusetts biotechnology giant Thermo Fisher Scientific has decided to stop selling genetic sequencing equipment in the Chinese region of Xinjiang, where the authorities have for years been persecuting the local Muslim population.

Xinjiang is the main home of China’s Uighur minority—a Turkic group that is primarily Muslim. As many as a million Uighurs have been interned in “re-education” camps that the authorities say are necessary to combat separatism and religious extremism. Heavy surveillance is commonplace in the oil-rich region, with cameras everywhere and people forced to install spyware on their smartphones.

Part of the surveillance effort is the collection not only of biometric data such as iris scans and fingerprints, but also DNA, as part of a health program. A database is being compiled of every person’s genetic information, not just that of criminal suspects, and it’s not at all clear that informed consent is involved.

Human Rights Watch said in late 2017 that Thermo Fisher was supplying some of the DNA sequencers for this project. The NGO confronted the company, only to be told that “it is not possible for us to monitor the use or application of all products we manufactured.”

Since then, however, U.S. politicians got involved, in particular Florida Sen. Marco Rubio, who pushed for a crackdown on the use of American technology in human rights violations by the Chinese authorities.

On Wednesday, the Wall Street Journal reported Thermo Fisher as saying it had taken account of “fact-specific assessments,” and that it recognizes “the importance of considering how our products and services are used—or may be used—by our customers.”

The manufacturers of DNA sequencers are mostly based in the U.S., with a couple coming from Europe and one notable new entrant to the market—BGI—being Chinese. BGI was reportedly set up with state support.

On a related note, the World Health Organization last week announced a new committee that will write guidelines for human genome editing. The decision comes after Chinese scientist He Jiankui last year claimed to have used DNA editing to produce HIV-resistant twins—the first babies in the world to have edited genes.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Big TechHealth
Are you addicted to technology? 6 questions experts use to help spot red flags
By Kristin StollerMarch 28, 2026
10 hours ago
HealthDietary Supplements
The Best Omega-3 Supplements (2026): An Expert Guide
By Emily PharesMarch 27, 2026
20 hours ago
HealthDietary Supplements
The 5 Best Online Dietitians of 2026: Help to Reach Your Nutrition Goals
By Christina SnyderMarch 27, 2026
20 hours ago
HealthDietary Supplements
Ritual Vitamins Review (2026): With Insight from an Expert
By Emily PharesMarch 27, 2026
21 hours ago
HealthDietary Supplements
The 4 Best Matcha Powders of 2026: Taste Tested by Our Team
By Emily PharesMarch 27, 2026
22 hours ago
HealthNASA
Astronaut’s medical mystery stumps doctors and NASA after he suddenly lost the ability to speak in space
By Marcia Dunn and The Associated PressMarch 27, 2026
23 hours ago

Most Popular

Success
Meetings are not work, says Southwest Airlines CEO—and he’s taking action by blocking his calendar every afternoon from Wednesday to Friday 
By Fortune EditorsMarch 27, 2026
1 day ago
Personal Finance
Current price of gold as of March 27, 2026
By Fortune EditorsMarch 27, 2026
1 day ago
AI
Exclusive: Anthropic acknowledges testing new AI model representing ‘step change’ in capabilities, after accidental data leak reveals its existence
By Fortune EditorsMarch 26, 2026
2 days ago
Personal Finance
Current price of silver as of Friday, March 27, 2026
By Fortune EditorsMarch 27, 2026
1 day ago
Economy
‘There is no silver lining in this trajectory’: Budget watchdog warns of financial, inflation, or currency crisis due to $39 trillion U.S. debt
By Fortune EditorsMarch 27, 2026
1 day ago
Success
This AI-proof career faces a 250,000-worker shortage—now the Trump administration is trying to revive the job millennials abandoned
By Fortune EditorsMarch 27, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.